Wie wird eine Katecholamintherapie bei Herzinsuffizienz durchgeführt?

Literatur

• 1 Binkley P F, Murray K D, Watson K M. et al . Dobutamine increases cardiac output of the total artificial heart: implications for vascular contribution of inotropic agents to augmented ventricular function.  Circulation. 1991;  84 1210-1215
• 2 Yamani M H, Haji S A, Starling R C. et al . Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congetsive heart failure: Heamodynamic efficacy, clinical outcome, and economic impact.  Am Heart J. 2001;  142 998-1002
• 3 Awan N A, Evenson M K, Needham K E. et al . Effect of combined nitroglycerin and dobutamine in left ventricular dysfunction.  Am Heart J. 1983;  106 35-40
• 4 Felker G M, O`Connor C M. Inotropic therapy for heart failure: An evidence-based approach.  Am Heart J. 2001;  142 393-401

Autor